Department of Cardiology, Faculty of Medicine, Beykent University, İstanbul, Turkey.
Department of Cardiology, Faculty of Medicine, İstinye University, İstanbul, Turkey.
Anatol J Cardiol. 2022 May;26(5):401-406. doi: 10.5152/AnatolJCardiol.2022.1350.
Venous diseases encompass a large spectrum of abnormalities in the venous system with complaints, such as aching and swelling. Enhanced external counterpulsa-tion, proven safe and effective in patients with coronary artery disease and chronic heart failure, is a technique that increases venous return and augments diastolic blood pres-sure. This study assessed the effects of enhanced external counterpulsation on symp-toms of venous disease using the Venous Insufficiency Epidemiological and Economic Study-Quality of Life/Symptoms questionnaire.
This study was designed prospectively for evaluating venous symptoms before and after enhanced external counterpulsation treatment. The study population con-sisted of 30 consecutive patients who were admitted to the cardiology clinic. The Venous Insufficiency Epidemiological and Economic Study-Quality of Life/Symptoms ques-tionnaire was applied to assess venous symptoms one day before and after enhanced external counterpulsation treatment.
The mean age of the patients was 64.62 ± 9.67 years. After 35 hours of enhanced external counterpulsation, 28 patients (93%) had at least 1 New York Heart Association functional class reduction compared with baseline and 43% of patients had 2 New York Heart Association functional classes improvement. The New York Heart Association class significantly decreased after enhanced external counterpulsation treatment (P<.001). There was a significant improvement in their swelling and night cramps symptoms compared with baseline (P< .001 and P = .05, respectively). Also, The left ventricular ejec-tion fraction significantly increased after the enhanced external counterpulsation treat- ment (P = .02).
The findings obtained in the present study suggested that patients treated with enhanced external counterpulsation showed a significant reduction in swelling and night cramps symptoms. Although the total VEIN score did not change after the enhanced external counterpulsation procedure, improvement in swelling and night cramps under-lines the beneficial effects of enhanced external counterpulsation through the venousvascular territory.
静脉疾病包括静脉系统的一系列异常，其症状包括疼痛和肿胀。增强型体外反搏已被证明在冠心病和慢性心力衰竭患者中是安全有效的，它是一种增加静脉回流和舒张血压的技术。本研究使用静脉功能不全流行病学和经济研究-生活质量/症状问卷评估增强型体外反搏对静脉疾病症状的影响。
本研究旨在前瞻性评估增强型体外反搏治疗前后静脉症状。研究人群由 30 名连续就诊于心内科的患者组成。应用静脉功能不全流行病学和经济研究-生活质量/症状问卷评估增强型体外反搏治疗前后的静脉症状。
患者的平均年龄为 64.62±9.67 岁。经过 35 小时的增强型体外反搏治疗后，与基线相比，28 名患者（93%）至少有 1 个纽约心脏协会功能等级降低，43%的患者有 2 个纽约心脏协会功能等级改善。增强型体外反搏治疗后纽约心脏协会功能等级显著降低（P<0.001）。与基线相比，肿胀和夜间痉挛症状显著改善（P<0.001 和 P=0.05）。此外，左心室射血分数在增强型体外反搏治疗后显著增加（P=0.02）。
本研究结果表明，接受增强型体外反搏治疗的患者肿胀和夜间痉挛症状显著减轻。虽然增强型体外反搏术后总的 VEIN 评分没有变化，但肿胀和夜间痉挛的改善强调了增强型体外反搏通过静脉血管区域的有益作用。
